NINDS Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–1588.
2.
EbingerMWinterBWendtM. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014;311(16):1622–1631.
3.
BerkhemerOAFransenPSBeumerD. A randomized trial of intra-arterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.
4.
CouttsSBDubucVMandziaJ. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion. Stroke. 2015;46(3):769–774.
5.
HillMDMartinRHMikulisD. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular repair (ENACT): a phase 2, randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2012;11(11):942–950.
6.
HopyanJCiaralloADowlatshahiD. Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiol. 2010;255(1):142–153.
7.
PuglieseMWShamyMCRodriguezR. How do neurologists diagnose acute stroke?Stroke. 2014;45(12):E285.
8.
GoyalMDemchukAMMenonBK. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–1030.
9.
BroderickJPPaleschYYDemchukAM. Endovascular therapy after intravenous tPA versus tPA alone for stroke. N Engl J Med. 2013;368(10):893–903.
10.
MenonBDemchukAM. Computed tomography angiography in the assessment of patients with stroke/TIA. Neurohospitalist. 2011;1(4):187–199.
11.
CouttsSBLevMHEliasziwM. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke. 2004;35(11):2472–2476.
12.
LumCAhmedEPatroS. Computed tomographic angiography and cerebral blood volume can predict final infarct volume and outcome after recanalization. Stroke. 2014;45(9):2683–2688.
13.
GladstoneDJAvivRDemchukAM. “Spot Sign” Selection of Intracerebral Hemorrhageto Guide Hemostatic Therapy (SPOTLIGHT)” Design of a Canadian image-guided randomized clinical trial of recombinant factor VIIa. Stroke. 2011;42(11):e597.
14.
GleasonSFurieKLLevMH. Potential influence of acute CT on inpatient costs in patients with ischemic stroke. Acad Radiol. 2001;8(10):955–964.
15.
QuinnTJDawsonJ. Acute ‘strokenomics’: efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Rev Pharmaceoecon Outcomes Res. 2009;9(6):513–522.
16.
HopyanJJGladstoneDJMalliaG. Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. Am J Neuroradiol. 2008;29(10):1826–1830.
